• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在基础条件下以及暴露于周期性应变后,核因子κB受体活化因子配体(RANKL)抑制平滑肌细胞中骨保护素的产生。

RANKL Inhibits the Production of Osteoprotegerin from Smooth Muscle Cells under Basal Conditions and following Exposure to Cyclic Strain.

作者信息

Davenport Colin, Harper Emma, Rochfort Keith D, Forde Hannah, Smith Diarmuid, Cummins Philip M

机构信息

School of Biotechnology, Dublin City University, Dublin, Ireland.

National Institute for Cellular Biotechnology, Dublin City University, Dublin, Ireland.

出版信息

J Vasc Res. 2018;55(2):111-123. doi: 10.1159/000486787. Epub 2018 Apr 10.

DOI:10.1159/000486787
PMID:29635231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6375687/
Abstract

Receptor activator of nuclear factor-κB ligand (RANKL) promotes vascular calcification, while osteoprotegerin (OPG) opposes it by blocking RANKL activity. It remains unclear which vascular cell populations produce and secrete OPG/RANKL. This study characterizes the production of OPG/RANKL from human aortic endothelial and smooth muscle cells (HAECs and HASMCs) under various conditions. HAECs and HASMCs were exposed to inflammatory stimuli (tumor necrosis factor-α or hyperglycemia) or physiological levels of hemodynamic (cyclic) strain. After 72 h, both cells and supernatant media were harvested for assessment of OPG/RANKL production. Based on initial findings, the experiments involving HASMCs were then repeated in the presence of exogenous RANKL. OPG was produced and secreted by HASMCs and (to a considerably lesser degree) HAECs under basal conditions. Inflammatory stimuli upregulated OPG production in both cell populations. Cyclic strain significantly upregulated OPG production in HASMCs. Neither cell population produced RANKL. Exposing HASMCs to exogenous RANKL inhibited basal OPG production and completely abrogated the strain-mediated upregulation of OPG. These data suggest that HASMCs are a significant source of OPG within the vasculature but that RANKL, once present, downregulates this production and appears capable of preventing the "protective" upregulation of OPG seen with HASMCs exposed to physiological levels of cyclic strain.

摘要

核因子κB受体激活剂配体(RANKL)促进血管钙化,而骨保护素(OPG)通过阻断RANKL活性来对抗血管钙化。目前尚不清楚哪些血管细胞群产生并分泌OPG/RANKL。本研究对人主动脉内皮细胞和平滑肌细胞(HAECs和HASMCs)在各种条件下OPG/RANKL的产生情况进行了表征。将HAECs和HASMCs暴露于炎症刺激(肿瘤坏死因子-α或高血糖)或生理水平的血流动力学(周期性)应变。72小时后,收集细胞和上清培养基以评估OPG/RANKL的产生。基于初步研究结果,随后在存在外源性RANKL的情况下重复涉及HASMCs的实验。在基础条件下,HASMCs产生并分泌OPG,HAECs也产生(程度要小得多)。炎症刺激上调了两种细胞群中OPG的产生。周期性应变显著上调了HASMCs中OPG的产生。两种细胞群均不产生RANKL。将HASMCs暴露于外源性RANKL会抑制基础OPG的产生,并完全消除应变介导的OPG上调。这些数据表明,HASMCs是脉管系统中OPG的重要来源,但RANKL一旦存在,就会下调这种产生,并且似乎能够阻止在暴露于生理水平周期性应变的HASMCs中看到的OPG“保护性”上调。

相似文献

1
RANKL Inhibits the Production of Osteoprotegerin from Smooth Muscle Cells under Basal Conditions and following Exposure to Cyclic Strain.在基础条件下以及暴露于周期性应变后,核因子κB受体活化因子配体(RANKL)抑制平滑肌细胞中骨保护素的产生。
J Vasc Res. 2018;55(2):111-123. doi: 10.1159/000486787. Epub 2018 Apr 10.
2
Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.骨保护素缺乏的平滑肌细胞中钙化增加:对核因子κB受体激活剂配体和白细胞介素6的依赖性。
J Vasc Res. 2014;51(2):118-31. doi: 10.1159/000358920. Epub 2014 Mar 7.
3
RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway.核因子κB受体活化因子配体(RANKL)通过RANK-骨形态发生蛋白4(BMP4)依赖的途径增加血管平滑肌细胞钙化。
Circ Res. 2009 May 8;104(9):1041-8. doi: 10.1161/CIRCRESAHA.108.189001. Epub 2009 Mar 26.
4
The function and meaning of receptor activator of NF-κB ligand in arterial calcification.核因子κB受体激活剂配体在动脉钙化中的作用及意义
J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):666-671. doi: 10.1007/s11596-015-1487-1. Epub 2015 Oct 22.
5
RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction.骨保护素(RANKL)而非 R- 分泌蛋白(R-Spondins)通过 LGR4 相互作用参与血管平滑肌细胞钙化。
Int J Mol Sci. 2024 May 24;25(11):5735. doi: 10.3390/ijms25115735.
6
RANKL promotes osteoblastic activity in vascular smooth muscle cells by upregulating endothelial BMP-2 release.核因子κB受体活化因子配体(RANKL)通过上调内皮细胞骨形态发生蛋白-2(BMP-2)的释放来促进血管平滑肌细胞中的成骨细胞活性。
Int J Biochem Cell Biol. 2016 Aug;77(Pt A):171-180. doi: 10.1016/j.biocel.2016.06.009. Epub 2016 Jun 23.
7
TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.TRAIL 缺陷通过调节 RANKL 加速动脉粥样硬化中的血管钙化。
PLoS One. 2013 Sep 5;8(9):e74211. doi: 10.1371/journal.pone.0074211. eCollection 2013.
8
Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System.Wnt/β-连环蛋白通路在动脉中层钙化中的作用及其对 OPG/RANKL 系统的影响。
Curr Med Sci. 2019 Feb;39(1):28-36. doi: 10.1007/s11596-019-1996-4. Epub 2019 Mar 13.
9
The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification.核因子κB配体受体富含亮氨酸重复序列的G蛋白偶联受体4的受体激活剂促成甲状旁腺激素诱导的血管钙化。
Nephrol Dial Transplant. 2021 Mar 29;36(4):618-631. doi: 10.1093/ndt/gfaa290.
10
TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.TLR2 通过协同抑制骨保护素和 IL-6 介导的 RANKL 诱导促进血管平滑肌细胞软骨分化和随后的钙化。
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):432-445. doi: 10.1161/ATVBAHA.118.311874.

引用本文的文献

1
Beyond Bone Remodeling: Denosumab's Multisystemic Benefits in Musculoskeletal Health, Metabolism, and Age-Related Diseases-A Narrative Review.超越骨重塑:地诺单抗在肌肉骨骼健康、代谢及与年龄相关疾病中的多系统益处——一篇叙述性综述
Biomedicines. 2025 Mar 17;13(3):732. doi: 10.3390/biomedicines13030732.
2
Mechanism Analysis of Vascular Calcification Based on Fluid Dynamics.基于流体动力学的血管钙化机制分析
Diagnostics (Basel). 2023 Aug 9;13(16):2632. doi: 10.3390/diagnostics13162632.
3
The Roles of RANK/RANKL/OPG in Cardiac, Skeletal, and Smooth Muscles in Health and Disease.

本文引用的文献

1
RANKL promotes osteoblastic activity in vascular smooth muscle cells by upregulating endothelial BMP-2 release.核因子κB受体活化因子配体(RANKL)通过上调内皮细胞骨形态发生蛋白-2(BMP-2)的释放来促进血管平滑肌细胞中的成骨细胞活性。
Int J Biochem Cell Biol. 2016 Aug;77(Pt A):171-180. doi: 10.1016/j.biocel.2016.06.009. Epub 2016 Jun 23.
2
Acute Hyperglycemia Impairs Vascular Function in Healthy and Cardiometabolic Diseased Subjects: Systematic Review and Meta-Analysis.急性高血糖损害健康及患有心脏代谢疾病受试者的血管功能:系统评价与荟萃分析
Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):2060-72. doi: 10.1161/ATVBAHA.115.305530. Epub 2015 Jun 25.
3
RANK/RANKL/OPG在心脏、骨骼和平滑肌健康与疾病中的作用
Front Cell Dev Biol. 2022 May 26;10:903657. doi: 10.3389/fcell.2022.903657. eCollection 2022.
4
TRAIL inhibits oxidative stress in human aortic endothelial cells exposed to pro-inflammatory stimuli.肿瘤坏死因子相关凋亡诱导配体可抑制暴露于促炎刺激下的人主动脉内皮细胞中的氧化应激。
Physiol Rep. 2020 Oct;8(20):e14612. doi: 10.14814/phy2.14612.
5
TRAIL signals, extracellular matrix and vessel remodelling.肿瘤坏死因子相关凋亡诱导配体信号、细胞外基质与血管重塑。
Vasc Biol. 2020 Jun 15;2(1):R73-R84. doi: 10.1530/VB-20-0005. eCollection 2020.
6
Biomechanical signal communication in vascular smooth muscle cells.血管平滑肌细胞中的生物力学信号传导
J Cell Commun Signal. 2020 Dec;14(4):357-376. doi: 10.1007/s12079-020-00576-1. Epub 2020 Aug 11.
Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.
促炎细胞因子下调血脑屏障表型涉及NADPH氧化酶依赖性活性氧生成:对内皮细胞间黏附连接和紧密连接的影响
PLoS One. 2014 Jul 3;9(7):e101815. doi: 10.1371/journal.pone.0101815. eCollection 2014.
4
Not at random location of atherosclerotic lesions in thoracic aorta and their prognostic significance in relation to the risk of cardiovascular events.胸主动脉粥样硬化病变的非随机位置及其与心血管事件风险的预后意义。
Pol J Radiol. 2013 Apr;78(2):38-42. doi: 10.12659/PJR.883944.
5
Mechanisms and clinical consequences of vascular calcification.血管钙化的机制和临床后果。
Front Endocrinol (Lausanne). 2012 Aug 6;3:95. doi: 10.3389/fendo.2012.00095. eCollection 2012.
6
Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification.雌激素通过血管 RANKL 系统抑制血管钙化:骨质疏松症和血管钙化的共同机制。
Circ Res. 2010 Aug 20;107(4):466-75. doi: 10.1161/CIRCRESAHA.110.216846. Epub 2010 Jul 1.
7
Passage-affected competitive regulation of osteoprotegerin synthesis and the receptor activator of nuclear factor-kappaB ligand mRNA expression in normal human osteoblasts stimulated by the application of cyclic tensile strain.周期性张应变刺激正常成骨细胞中骨保护素合成和核因子-κB 配体 mRNA 表达的通路上的竞争调控。
J Bone Miner Metab. 2009;27(6):653-62. doi: 10.1007/s00774-009-0085-3. Epub 2009 May 19.
8
Role of TNF-alpha in vascular dysfunction.肿瘤坏死因子-α在血管功能障碍中的作用。
Clin Sci (Lond). 2009 Feb;116(3):219-30. doi: 10.1042/CS20080196.
9
Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.骨保护素和核因子κB受体活化因子配体对血管生成和内皮细胞功能有不同的调节作用。
Angiogenesis. 2009;12(1):35-46. doi: 10.1007/s10456-008-9127-z. Epub 2008 Dec 23.
10
Effects of cyclic strain on endothelial cell apoptosis and tubulogenesis are dependent on ROS production via NAD(P)H subunit p22phox.循环应变对内皮细胞凋亡和血管生成的影响取决于通过NAD(P)H亚基p22phox产生的活性氧。
Microvasc Res. 2009 Mar;77(2):125-33. doi: 10.1016/j.mvr.2008.08.001. Epub 2008 Aug 27.